Immunomic Therapeutics logo

Immunomic Therapeutics

Website

Team & Investors

Leadership, board of directors, and investment partners

Executives
0
Board Members
0
Investors
17
Total Funding
$121.9M
Investors
17 investors across all rounds
A+
Angels + Life.Sci Investors Network
AP
Astellas Pharma
DG
Daniel Geselowitz
GZ
Gary Zebrowski
H(
HLB (Holding Companies)

+12 more investors

Sign in to view all

Explore More Data
Detailed analysis for Immunomic Therapeutics

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

Immunomic Therapeutics Leadership & Investors

Immunomic Therapeutics is led by a team of experienced leaders. The company has attracted investment from 17 institutional and strategic investors.

Who Has Invested in Immunomic Therapeutics?

Immunomic Therapeutics has raised $121.9M from 17 investors including venture capital firms, private equity investors, and strategic partners.

Investment Opportunity

Accredited investors can access Immunomic Therapeutics shares through secondary market platforms like Premier Alternatives, joining the company's existing institutional investor base.